West Pharmaceutical Services | WST - Fremdkapital

Aktienkurs
237.03
Täglich Wechseln
-3.30 -1.37%
Monatlich
-2.94%
Jährlich
3.65%
Q1 Prognose
229.92




Fremdkapital Veränderung Datum
Align Technology USD 0 0 2024-12
Avanos Medical USD 90.3M 3.1M 2025-12
Baxter International USD 9.47B 726M 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Cerus USD 64.86M 22K 2024-12
Charles River Laboratories USD 2.14B 49.09M 2025-12
Cooper Companies USD 1.88B 578.5M 2025-12
Dentsply International USD 2.02B 2M 2025-12
Haemonetics USD 919.99M 406K 2025-12
ICU Medical USD 1.27B 48.01M 2025-12
Insulet USD 930.8M 4.1M 2025-12
Integra LifeSciences USD 1.86B 63.76M 2025-12
IQVIA Holdings USD 13.88B 1.09B 2025-12
J&J USD 39.44B 30M 2025-12
Medtronic USD 27.88B 255M 2025-12
Merit Medical Systems USD 734.04M 1.12M 2025-12
Neogen USD 792.93M 396K 2025-09
OraSure Technologies USD 100K 17K 2025-12
Quidel USD 2.47B 2.47B 2025-12
Repligen USD 542.21M 4.29M 2025-12
Rockwell Medical USD 8.65M 89K 2025-06
Solventum Corp USD 5.04B 102M 2025-12
STAAR Surgical USD 42K 42K 2023-12
Terumo JPY 99.9B 12M 2025-12
Utah Medical Products USD 0 0 2022-03
West Pharmaceutical Services USD 202.8M 100K 2025-12